Skip to content

Comparison of aerobic and resistance training on interleukin-18 and c- reactive protein in elderly men

Comparison of aerobic and resistance training on interleukin-18 and c- reactive protein in elderly men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013031612827N1
Enrollment
30
Registered
2013-11-07
Start date
2012-04-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly. Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention 1: Intervention 1: The intervention group followed an aerobic exercise program for 12 weeks. This program includes warm up with stretching and then walking on a treadmill speed is increas
Intervention 1: The intervention group followed an aerobic exercise program for 12 weeks. This program includes warm up with stretching and then walking on a treadmill speed is increased. This one hou
Intervention 3: Daily life no regular physical activity in the control group
Intervention 2: The intervention group followed an resistance exercise program for 12 weeks. Resistance training protocol consisted of 3 sessions per week, 9 stations, 3 sets 8-12 repetitions in each

Sponsors

Islamic Azad University, Khorasgan (Isfahan)
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: male, 65 to 80 years, without experience of regular physical activity in one year before beginning of the study. Exclusion criteria: history of cardiovascular diseases, cancer, high blood pressure, diabetes, thyroid disease, addiction to any smoking, alcohol and narcotic substances.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Interleukin-18. Timepoint: Before and after 12 weeks of intervention. Method of measurement: ELISA kit for Interleukin-18.;Body Mass Index. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Weight divided by height squared.;Weight. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Weight meter Seca.;C-reactive protein. Timepoint: Before and after 12 weeks of intervention. Method of measurement: Nephlometric method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKeihan Ghatre Samani (PhD)

Shahrekord University of Medical Sciences

kgsamani@yahoo.com+98 38 1334 6721

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026